Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hall, Charlotte L.; Taylor, John A.; Newell, Karen; Baldwin, Laurence; Sayal, Kapil; Hollis, Chris (2016)
Publisher: Royal College of Psychiatrists
Journal: BJPsych open
Languages: English
Types: Article
Subjects: Paper

Classified by OpenAIRE into

mesheuropmc: mental disorders, health care economics and organizations, behavioral disciplines and activities
Background The landmark US Multimodal Treatment of ADHD (MTA) study established the benefits of individualised medication titration and optimisation strategies to improve short- to medium-term outcomes in attention-deficit hyperactivity disorder (ADHD). This individualised medication management approach was subsequently incorporated into the National Institute for Health and Care Excellence (NICE) ADHD Clinical Guidelines (NICE CG78). However, little is known about clinicians’ attitudes towards implementing these medication management strategies for ADHD in routine care. Aims To examine National Health Service (NHS) healthcare professionals’ consensus on ADHD medication management strategies. Method Using the Delphi method, we examined perceptions on the importance and feasibility of implementing 103 ADHD treatment statements from sources including the UK NICE ADHD guidelines and US medication management algorithms. Results Certain recommendations for ADHD medication management were judged as important and feasible to implement, including a stepwise titration of stimulant medication. Other recommendations were perceived as important but not feasible to implement in routine practice, such as weekly clinic follow-up with the family during titration and collection of follow-up symptom questionnaires. Conclusions Many of the key guideline recommendations for ADHD medication management are viewed by clinicians as important and feasible to implement. However, some recommendations present significant implementation challenges within the context of routine NHS clinical care in England. Declaration of interest C.H. and K.S. were members of the Guideline Development Group for the NICE ADHD Clinical Guideline (NICE CG78). Copyright and usage © 2016 The Royal College of Psychiatrists. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. Attentiondeficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000; 48: 9-20.
    • 2 Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahsey A, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cogn Psychother 1999; 13: 215-26.
    • 3 National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. Clinical guideline 72. NICE, 2008.
    • 4 MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56: 1073-86.
    • 5 Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001; 40: 168-79.
    • 6 Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, et al. Costeffectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry 2005; 162: 1628-36.
    • 7 Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. Attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 908-19.
    • 8 Pliszka SR, Lopez M, Crismon ML, Toprac MG, Hughes CW, Emslie GJ, et al. A feasibility study of the Children's Medication Algorithm Project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry 2003; 42: 279-87.
    • 9 Sheldon T, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I, et al. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004; 329: 999.
    • 10 Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 2010; 95: 24-7.
    • 11 Hall CL, Walker GM, Valentine AZ, Guo B, Kaylor-Hughes C, James M, et al. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD - 'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial. BMJ Open 2014; 4: e006838.
    • 12 Hall CL, Newell K, Taylor J, Sayal K, Swift KD, Hollis C. 'Mind the gap' - mapping services for young people with ADHD transitioning from child to adult mental health services. BMC Psychiatry 2013; 13: 186.
    • 13 Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2000; 3: 77-101.
    • 14 Dalkey N, Helmer O. An experimental application of the DELPHI method to the use of experts. Manage Sci 1963; 9: 458-67.
    • 15 Morrison AP, Barratt S. What are the components of CBT for psychosis? A Delphi study. Schizophr Bull 2010; 36: 136-42.
    • 16 Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996; 35: 1304-13.
    • 17 Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006; 333: 417.
    • 18 Herdman M, Rajmil L, Ravens-Sieberer U, Bullinger M, Power M, Alonso J. Expert consensus in the development of a European health-related quality of life measure for children and adolescents: a Delphi study. Acta Paediatr 2002; 91: 1385-90.
    • 19 Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ 1995; 311: 376-80.
    • 20 Langlands RL, Jorm AF, Kelly CM, Kitchener BA. First aid recommendations for psychosis: using the Delphi method to gain consensus between mental health consumers, carers, and clinicians. Schizophr Bull 2008; 34: 435-43.
    • 21 Bell AS. A critical review of ADHD diagnostic criteria: what to address in the DSMV. J Atten Disord 2011; 15: 3-10.
    • 22 Gathje RA, Lewandowski LJ, Gordon M. The role of impairment in the diagnosis of ADHD. J Atten Disord 2008; 11: 529-37.
    • 23 Gordon M, Antshel K, Faraone S, Barkley R, Lewandowski L, Hudziak JJ. Symptoms versus impairment: the case for respecting DSM-IV's Criterion D. J Atten Disord 2006; 9: 465-75.
    • 24 Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry 2012; 53: 1036-10.
    • 25 Mitsis EM, McKay KE, Schulz KP, Newcorn JH, Halperin JM. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinicreferred sample. J Am Acad Child Adolesc Psychiatry 2000; 39: 308-13.
    • 26 Conners CK. Conners Rating Scales-Revised (CRS-R). Multi-Health Systems, 1997.
    • 27 Tettenborn M, Prasad S, Poole L, Steer C, Coghill D, Harpin V, et al. The provision and nature of ADHD services for children/adolescents in the UK: results from a nationwide survey. Clin Child Psychol Psychiatry 2008; 13: 287-304.
    • 28 Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 2001; 40: 188-96.
    • 29 Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008; 8: 38.
    • 30 Hall CL, Taylor J, Moldavsky M, Marriott M, Pass S, Newell K, et al. A qualitative process evaluation of electronic session-by-session outcome measurement in child and adolescent mental health services. BMC Psychiatry 2014; 14: 113.
    • 31 Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Practical Assess Res Eval 2007; 12: 1-8.
    • 32 Akins R, Tolson H, Cole B. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 2005; 5: 37.
    • 33 Adams AS, Soumerai SB, Lomas J, Ross-Degnan D. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999; 11: 187-92.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article